XANDO
DÍAZ VILLAMARÍN
DOCENTE INVITADO
LUIS JAVIER
MARTÍNEZ GONZÁLEZ
PROF. AYUDANTE DOCTOR
Publicacións nas que colabora con LUIS JAVIER MARTÍNEZ GONZÁLEZ (10)
2023
-
A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study
The Lancet, Vol. 401, Núm. 10374, pp. 347-356
2022
2021
-
Genetic polymorphisms affecting ranibizumab response in high myopia patients
Pharmaceutics, Vol. 13, Núm. 11
-
Pharmacogenetic polymorphisms affecting bisoprolol response
Biomedicine and Pharmacotherapy, Vol. 142
2020
-
Genetic variants affecting anti-vegf drug response in polypoidal choroidal vasculopathy patients: A systematic review and meta-analysis
Genes, Vol. 11, Núm. 11, pp. 1-13
2019
-
Cost-effectiveness analysis of pharmacogenomics-guided clopidogrel treatment in Spanish patients undergoing percutaneous coronary intervention
Pharmacogenomics Journal, Vol. 19, Núm. 5, pp. 438-445
-
Pharmacogenetics in the Treatment of Cardiovascular Diseases and its current progress regarding Implementation in the Clinical Routine
Genes, Vol. 10, Núm. 4
2016
-
A new pharmacogenetic algorithm to predict the most appropriate dosage of acenocoumarol for stable anticoagulation in a mixed Spanish population
PLoS ONE, Vol. 11, Núm. 3
-
Genetic polymorphisms influence on the response to clopidogrel in peripheral artery disease patients following percutaneous transluminal angioplasty
Pharmacogenomics, Vol. 17, Núm. 12, pp. 1327-1338
-
Results of genotype-guided antiplatelet therapy in patients who undergone percutaneous coronary intervention with stent
International Journal of Cardiology, Vol. 225, pp. 289-295